The Centers for Medicare & Medicaid Services announced on Wednesday a new opportunity for those who failed to comply with the individual mandate in 2018 to avoid the corresponding tax penalty. The new policy allows hardship exemptions to be claimed without “the documentary evidence or written explanation generally required.”
HHS Secretary Alex Azar on Thursday touted the CMS’ recent push for accountable care organizations to assume more risk.
In an address to an advisory group on physician-focused payment models, Azar said the Center for Medicare & Medicaid Innovation would be launching “bold” new models to reform value-based models that include making physicians and hospitals into “accountable navigators of the health system.”
HHS wants to encourage providers to enter value-based care agreements with each other, and it’s researching whether it can offer new legal protections for those arrangements.
Yesterday marked 100 days since President Trump announced his drug pricing blueprint, the basic goal of which is to “lower prices” somehow. How successful has it been?
In thinking about this question, it is useful to remind oneself that drug production and distribution is largely market-based, and the lesson of the market framework is that prices fall only if there is an increase in supply, a decrease in demand, or a reduction in taxes and other overhead-like costs.
Short-term health insurance plans provide affordable, individualized options for people who are between jobs, taking time off to care for a sick family member, or can’t afford the few options available to them on the exchanges.
Health and Human Services Secretary Alex Azar announced a finalized rule change to ObamaCare that once again makes short-term, catastrophic health-insurance plans available—a revision that will bring formerly marginalized Americans like me back into the health-insurance fold.
The Trump administration announced a new rule that will help reduce prescription drug prices for many seniors enrolled in the Medicare Advantage program. How does it work? By reforming a long-standing quirk in Medicare that prevented drugmakers from competing with each other.
The Centers for Medicaid & Medicare Services is continuing the drumbeat of modernizing the two gargantuan programs it runs to generate more accountability, greater transparency, and provide better value for both patients and taxpayers.
A new Treasury ruling will allow people to buy health insurance that has lower premiums, lower deductibles and broader networks of providers. For the first time since the enactment of Obamacare, people will be able to buy insurance that meets individual and family needs rather than the needs of politicians and bureaucrats. They will also be able to pay actuarially fair premiums.
Insurers participating in Medicare Advantage will be able to negotiate directly with drugmakers in an effort to lower the cost of prescription medications under a new policy announced by the Trump administration.